Dual diagnosis in psychiatric inpatients: Prevalence and general characteristics;Patología dual en pacientes psiquiátricos hospitalizados: Prevalencia y características generales

Investigacion Clinica

Volumn 49, Issue 2, 2008, Pages 195-205

  Rodríguez Jiménez, Roberto ^a,b   Aragüés, María ^a,b   Jiménez Arriero, Miguel Angel ^a,b   Ponce, Guillermo ^a,b   Muñoz, Antonio ^a,c   Bagney, Alexandra ^a   Hoenicka, Janet ^a,b   Palomo, Tomás ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c Servicios de Salud Mental de Usera   (Spain)

Author keywords

Comorbidity; Dual diagnosis; Hospitalization unit; Inpatient; Prevalence; Psychiatry; Substance use disorder

Indexed keywords

ALCOHOL; CANNABIS; COCAINE;

ADULT; ALCOHOL PSYCHOSIS; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HOSPITAL; MENTAL PATIENT; PREVALENCE; SCHIZOPHRENIA; SPAIN; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

ADULT; ALCOHOLISM; COCAINE-RELATED DISORDERS; COHORT STUDIES; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INPATIENTS; MALE; MARIJUANA ABUSE; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; OPIOID-RELATED DISORDERS; PREVALENCE; PSYCHIATRIC DEPARTMENT, HOSPITAL; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SEX FACTORS; SPAIN; SUBSTANCE-RELATED DISORDERS;

EID: 49449108390     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Drake RE. Dual diagnosis. Psychiatry 2004; 3(10):60-63.
2. Hunt GE, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 2002; 54:253-264.
3. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Violence and severe mental illness: the effects of substance abuse and non adherence to medication. Am J Psychiatry 1998; 155: 226-231.
4. Soyka M. Substance misuse, psychiatric disorder and violent and disturbed behaviour. Br J Psychiatry 2000; 176:345-350.
5. Appleby L, Shaw J, Amos T, McDonnell R, Harris C, McCann K, Kiernan K, Davies S, Bickley H, Parsons R. Suicide within 12 months of contact with mental health services: national clinical survey. Br Med J 1999; 318:1235-1239.
6. Hoff RA, Rosenheck RA. The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatr Serv 1999; 50:1309-1315.
7. McCrone P, Menezes PR, Johnson S, Scott H, Thornicroft G, Marshall J, Bebbington P, Kuipers E. Service use and costs of people with dual diagnosis in South London. Acta Psychiatr Scand 2000; 101:464-472.
8. Dickey B, Normand SLT, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 2002; 53:861-867.
9. Owen RR, Fischer EP, Booth BM, Cuffel BJ. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 1996; 47:853-858.
10. Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O'Callaghan E. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr Serv 2001; 52:161-166.
11. Carey MP, Carey KB, Meisler AW. Psychiatric symptoms in mentally ill chemical abusers. J Nerv Ment Dis 1991; 179:136-138.
12. th edition; American Psychiatric Association, 2000.
13. George TP, Krystal JH. Comorbidity of psychiatric and substance abuse disorders. Curr Opin Psychiatry 2000; 13:327-331.
14. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264:2511-2518.
15. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. Arch Gen Psychiatry 1996; 53:1022-1031.
16. Margolese HC, Malchy L, Negrete JC, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 2004; 67:157-166.
17. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N, Ford C. Comorbidity of Substance Misuse and Mental Illness Collaborative study team. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003; 183:304-313.
18. Driessen M, Veltrup C, Wetterling T, John U, Dilling H. Axis I and axis II comorbidity in alcohol dependence and the two types of alcoholism. Alcohol Clin Exp Res 1998; 22:77-86.
19. Lambert MT, Griffith JM, Hendrickse W. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center. Psychiatr Serv 1996; 47:1104-1107.
20. Otto MW, Pollack MH, Sachs GS, O'Neil CA, Rosenbaum JF. Alcohol dependence in panic disorder patients. J Psychiatr Res 1992; 26:29-38.
21. Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorder. Am J Psychiatry 1990; 147:1002-1007.
22. Crowley TJ, Chesluk D, Dilts S, Hart R. Drug and alcohol abuse among psychiatric admissions. A multidrug clinical-toxicologic study. Arch Gen Psychiatry 1974; 30:13-20.
23. Brady K, Casto S, Lydiard RB, Malcolm R, Arana G. Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 1991; 17:389-397.
24. Cantwell R, Brewin J, Glazebrook C, Dalkin T, Fox R, Medley I, Harrison G. Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry 1999; 174:150-153.
25. Havassy BE, Arns PG. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Psychiatr Serv 1998; 49:935-940.
26. Barnaby B, Drummond C, McCloud A, Burns T, Omu N. Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. Br Med J 2003; 327:783-784.
27. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1991; 148:224-230.
28. Mueser KT, Yarnold PR, Rosenberg SD, Swett C Jr, Miles KM, Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates and subgroups. Schizophr Bull 2000; 26:179-192.
29. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24:443-455.
30. Arias-Horcajadas F, Sánchez-Romero S, Padin-Calo JJ. Relevance of drug use in clinical manifestations of schizophrenia. Actas Esp Psiquiatr 2002; 30:65-73.
31. Lehman AF, Myers CP, Corty E, Thompson JW. Prevalence and patterns of "dual diagnosis" among psychiatric inpatients. Compr Psychiatry 1994; 35:106-112.
32. Mathers DC, Ghodse AH, Caan AW, Scott SA. Cannabis use in a large sample of acute psychiatric admissions. Br J Addict 1991; 86:779-784.
33. Dervaux A, Bayle FJ, Krebs MO. Substance misuse among people with schizophrenia: similarities and differences between the UK and France. Br J Psychiatry 2002; 180:381.
34. Karam EG, Yabroudi PF, Melhem NM. Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon. Compr Psychiatry 2002; 43:463-468.
35. Blixen CE, McDougall GJ, Suen LJ. Dual diagnosis in elders discharged from a psychiatric hospital. Int J Geriatr Psychiatry 1997; 12:307-313.
36. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001; 48: 69-82.
37. Soyka M, Albus M, Kathmann N, Finelli A, Hofstetter S, Holzbach R, Immler B, Sand P. Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur Arch Psychiatry Clin Neurosci 1993; 242: 362-372.
38. Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull 2000; 26:105-118.
39. Farris C, Brems C, Johnson ME, Wells R, Burns R, Kletti N. A comparison of schizophrenic patients with or without coexisting substance use disorder. Psychiatr Q 2003; 74: 205-222.
40. Swindle RW, Phibbs CS, Paradise MJ, Recine BP, Moos RH. Inpatient treatment for substance abuse patients with psychiatric disorders: a national study of determinants of readmission. J Subst Abuse 1995; 7:79-97.
41. Clark RE, Ricketts SK, McHugo GJ. Legal system involvement and costs for persons in treatment for severe mental illness and substance use disorders. Psychiatr Serv 1999; 50:641-647.
42. Theriot MT, Segal SP. Involvement with the criminal justice system among new clients at outpatient mental health agencies. Psychiatr Serv 2005; 56:179-185.
43. Fenton WS. Comorbid conditions in schizophrenia. Curr Opin Psychiatry 2001; 14:17-23.
44. Comtois KA, Tisdall WA, Holdcraft LC, Simpson T. Dual diagnosis: impact of family history. Am J Addict 2005; 14:291-299.
45. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, Zhang H, O'Malley SS, Rounsaville BJ. Familial transmission of substance use disorders. Arch Gen Psychiatry 1998; 55:973-979.
46. Bergen AW, Caporaso N. Cigarette smoking. J Natl Cancer Inst 1999; 91: 1365-1375.
47. Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005; 14:106-123.
48. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA 2000; 284:2606-2610.
49. de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res 2002; 56:47-54.
50. Baigent MF. Understanding alcohol misuse and comorbid psychiatric disorders. Curr Opin Psychiatry 2005; 18:223-228.
51. Sevy S, Robinson DG, Solloway S, Alvir JM, Woerner MG, Bilder R, Goldman R, Lieberman J, Kane J. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 2001; 1014:367-374.